截至2026年1月13日收盘，福莱新材（605488）报收于37.2元，较前一交易日上涨0.49%，最新总市值为 104.24亿元。该股当日开盘36.61元，最高38.18元，最低35.51元，成交额达5.92亿元，换手率为5.81%。 公司近日发布公告称，浙江福莱新材料股份有限公司收到中国证券监督管理委员会出具的《关于同意浙 江福莱新材料股份有限公司向特定对象发行股票注册的批复》（证监许可〔2026〕33号），同意公司向 特定对象发行股票的注册申请。批复自同意注册之日起12个月内有效。公司需严格按照报送上海证券交 易所的申报文件和发行方案实施发行，并在发生重大事项时及时报告。公司将根据批复要求及股东会授 权，在规定期限内办理相关事宜并履行信息披露义务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 最新公告列表 《福莱新材关于向特定对象发行股票申请获得中国证券监督管理委员会同意注册批复的公告》 ...

Core Viewpoint - Zhejiang Fulai New Materials Co., Ltd. has received approval from the China Securities Regulatory Commission (CSRC) for a stock issuance to specific investors, with a total fundraising amount not exceeding 707 million yuan [2][2]. Group 1: Regulatory Approval - The CSRC has granted approval for Fulai New Materials' application to issue stocks to specific investors, valid for 12 months from the date of approval [2][2]. - The company will proceed with the stock issuance in accordance with the approval document and relevant laws, as well as the authorization from the shareholders' meeting [2][2]. Group 2: Fundraising Purpose - The net proceeds from the stock issuance, after deducting issuance costs, are intended for investment in projects including the expansion of label printing materials, upgrading electronic-grade functional materials, enhancing the R&D center, and supplementing working capital [2][2]. - The company believes that these fundraising projects will help seize market opportunities, expand business scale, achieve industrial upgrades, and enhance core competitiveness and sustainable development capabilities, indicating a positive market outlook and economic benefits [2][2].

Group 1 - Shoukai Co. achieved a signed area of 125.72 million square meters and a signed amount of 17.845 billion yuan in 2025 [1] - Tongda Hai expects a net loss for the year 2025 [2] - Jiuri New Materials' subsidiary has entered the trial production phase for a project with an annual capacity of 350 tons of hydroxy ketone [3] Group 2 - Jixin Technology's shareholder plans to reduce their stake by up to 1% [4] - Fulai New Materials received approval from the CSRC for a stock issuance [5] - Yaqi International plans to sign a strategic cooperation framework agreement with Zhongnong Holdings [6] Group 3 - Sanwei Co.'s controlling shareholder plans to transfer up to 5.10% of shares [7] - Lekai Film's subsidiary plans to invest 97.6675 million yuan in a TAC functional film production line [8] - China Power Construction's subsidiary signed two major contracts totaling approximately 15.589 billion yuan [9] Group 4 - Shunhao Co. plans to increase its investment in a subsidiary by 74.98 million yuan [10] - Jieneng Wind Power reported a cumulative power generation of 12.417 billion kWh in 2025, a year-on-year increase of 1.43% [11] - Zhongjian Technology's H-share issuance application has been accepted by the CSRC [12] Group 5 - Hendi Pharmaceutical expects a net profit decrease of 57.4% to 66.14% in 2025 [13] - Haopeng Technology anticipates a net profit increase of 113.69% to 141.09% in 2025 [14] - Lingang Co. expects a net loss of 1.45 billion to 1.67 billion yuan in 2025 [15] Group 6 - Chuan Investment Energy reported a cumulative power generation of 6.627 billion kWh in 2025, a year-on-year increase of 13.85% [16] - Tengyuan Cobalt expects a net profit increase of 50.02% to 69.87% in 2025 [17] - Huazhi Jie plans to repurchase shares worth 30 million to 50 million yuan [18] Group 7 - Opto has won a bid for a 120 million yuan project from GoerTek [19] - Shanghai Construction reported a new contract amount of 252.942 billion yuan in 2025, a year-on-year decrease of 34.98% [20] - Hangfa Control expects a net profit decrease of 52.02% to 58.02% in 2025 [22] Group 8 - Shimao Energy is planning a change in control and will continue to suspend trading [23] - Shenwan Hongyuan Securities received approval for a bond issuance of up to 60 billion yuan [24] - Jingjiawei signed a strategic cooperation letter of intent with Jing'an Technology [25] Group 9 - Pianzaihuang completed the first subject enrollment for a clinical trial of a new drug [26] - Placo's subsidiary received a new veterinary drug registration certificate [27] - Zhongli Co. plans to reduce its stake by up to 0.75% [28] Group 10 - Solar Energy received renewable energy subsidies of 3.318 billion yuan in 2025, a year-on-year increase of 142.9% [29] - Palm Co. has filed a lawsuit to recover 144 million yuan in project payments [30][31] - Yongjin Co. plans to invest 2.658 billion yuan in a new stainless steel project [32] Group 11 - BAIC Blue Valley plans to increase its stake by 14.5 million to 16.4 million yuan [33] - Lingyun Light's stock issuance application has been approved by the CSRC [34] - Hongbo New Materials expects a net loss in 2025 [35] Group 12 - Shanghai Pharmaceuticals received approval for the listing of a new antifungal drug [36] - Changjiang Electric reported a net profit of 34.167 billion yuan in 2025, a year-on-year increase of 5.14% [37] - Weilan Bio received a new veterinary drug registration certificate [38] Group 13 - Pingzhi Information's subsidiary is expected to win a procurement project worth approximately 37.5884 million yuan [39]

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 福莱新材(605488.SH)公告称，公司近日收到中国证券监督管理委员会出具的《关于同意浙江福莱新材 料股份有限公司向特定对象发行股票注册的批复》，同意公司向特定对象发行股票的注册申请，批复自 同意注册之日起12个月内有效。公司将按照批复文件和相关法律法规的要求及公司股东会的授权，在规 定期限内办理本次向特定对象发行股票的相关事宜，并及时履行信息披露义务。 ...

四、自同意注册之日起至本次发行结束前，你公司如发生重大事项，应及时 报告上海证券交易所并按有关规定处理。" 浙江福莱新材料股份有限公司（以下简称"公司"）近日收到中国证券监督 管理委员会出具的《关于同意浙江福莱新材料股份有限公司向特定对象发行股票 注册的批复》（证监许可〔2026〕33 号），主要内容如下： "一、同意你公司向特定对象发行股票的注册申请。 二、你公司本次发行应严格按照报送上海证券交易所的申报文件和发行方案 实施。 三、本批复自同意注册之日起 12 个月内有效。 | 证券代码：605488 | 证券简称：福莱新材 | 公告编号：临 | 2026-002 | | --- | --- | --- | --- | | 债券代码：111012 | 债券简称：福新转债 | | | 浙江福莱新材料股份有限公司 关于向特定对象发行股票申请获得中国证券监督管理 委员会同意注册批复的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 公司将按照上述批复文件和相关法律法规的要求及公司股东会的授权，在规 定期限内办理本次向特定对象发 ...

21智讯1月13日电，福莱新材公告，公司近日收到中国证券监督管理委员会出具的《关于同意浙江福莱 新材料股份有限公司向特定对象发行股票注册的批复》（证监许可〔2026〕33号），批复内容包括： 一、同意公司向特定对象发行股票的注册申请；二、本次发行应严格按照报送上海证券交易所的申报文 件和发行方案实施；三、本批复自同意注册之日起12个月内有效；四、自同意注册之日起至本次发行结 束前，如发生重大事项，应及时报告上海证券交易所并按有关规定处理。公司将按照上述批复文件和相 关法律法规的要求及公司股东会的授权，在规定期限内办理本次向特定对象发行股票的相关事宜，并及 时履行信息披露义务，敬请投资者注意投资风险。 ...

福莱新材公告称，近日收到中国证监会出具的批复，同意公司向特定对象发行股票的注册申请。本次发 行应按报送上海证券交易所的申报文件和发行方案实施，批复自同意注册之日起12个月内有效。自同意 注册日起至发行结束前，若发生重大事项，公司应及时报告上交所并处理。公司将在规定期限内办理相 关事宜并履行信披义务。 ...

Core Viewpoint - The company reported a decrease in the number of shareholders and a mixed performance in stock price and financial results, indicating potential shifts in investor sentiment and operational challenges [2] Group 1: Shareholder Information - As of January 10, 2026, the company had 28,800 shareholders, a decrease of 3,900 from the previous period, representing a decline of 11.93% [2] Group 2: Stock Performance - The closing price of the company's stock was 37.02 yuan, reflecting an increase of 5.98%. Since the concentration of shares began, the stock price has cumulatively risen by 7.77%. The stock experienced 2 days of increases and 4 days of decreases during the reporting period [2] Group 3: Financial Performance - For the first three quarters, the company achieved a revenue of 2.097 billion yuan, marking a year-on-year growth of 18.09%. However, the net profit was 64.6 million yuan, which represents a year-on-year decline of 7.83%. The basic earnings per share were 0.2300 yuan, and the weighted average return on equity was 4.28% [2]

（文章来源：证券日报） 证券日报网讯 1月12日，福莱新材在互动平台回答投资者提问时表示，截至2026年1月10日，公司股东 总户数约为2.88万户。 ...

Group 1 - On January 12, a total of 4 listed companies had their restricted shares unlocked, with a total market value of approximately 6.055 billion yuan [1] - The specific details of the restricted share unlocks are as follows: [1] - Zhongbai Group (Stock Code: 000759) had 7.3776 million shares unlocked under equity incentive restrictions [1] - Xianghe Industrial (Stock Code: 603500) had 554,000 shares unlocked under equity incentive restrictions [1] - Tianxin Pharmaceutical (Stock Code: 603235) had 263 million shares unlocked with an extended lock-up period [1] - Fulei New Materials (Stock Code: 605488) had 40,000 shares unlocked under equity incentive restrictions [1]